The following is a summary of “Development of a patient decision aid for type 2 diabetes mellitus: a patient-centered ...

Although patent ductus arteriosus (PDA) leading to significant ... debate is ongoing about the selection of the treatment method, and there is still no consensus about the benefit-side effect ...

117 patients showed a PDA at first evaluation. 88 newborns were treated with ibuprofen for HsPDA; after treatment 60 patients had a closed ductus (responders) while 28 were non-responders.

Cite this: Current Controversies in the Diagnosis and Treatment of Patent Ductus Arteriosus in Preterm Infants - Medscape - Aug 01, 2003. The DA of a very preterm infant has minimal constriction ...

Background Ibuprofen treatment of patent ductus arteriosus (PDA) has been shown to be as effective as indomethacin in small randomized controlled trials, with possibly fewer adverse effects.

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants SOUTH JORDAN, Utah, March 10, ...

Merit Medical Systems has enrolled the first patient in the multi-centre PREEMIE study to assess the efficacy and safety of the Bloom Micro Occluder System, aimed at treating patent ductus arteriosus ...

The authors suggest that GATA6 could serve as a biomarker for distinguishing PDA subtypes. Patients with low GATA6 expression are more likely to have treatment-resistant basal-like PDA ...

A hemodynamically significant or large PDA (hsPDA) can negatively affect a baby’s health and require treatment to close the opening. Today, minimally invasive treatment options offer ...